A multicomponent snapshot of pharmaceuticals and pesticides in the river Meuse basin

Environmental Toxicology and Chemistry

Volumn 32, Issue 11, 2013, Pages 2449-2459

  Houtman, Corine J ^a   ten Broek, Rob ^a   de Jong, Kevin ^a   Pieterse, Bart ^b   Kroesbergen, Jan ^a  

^a Water Laboratory   (Netherlands)

^b BIODETECTION SYSTEMS B V   (Netherlands)

Author keywords

Drinking water; Environmental chemistry; Pharmaceutical; Principal component analysis; River basin; Water quality

Indexed keywords

ANALYTICAL METHOD; ANTI DIABETICS; ENVIRONMENTAL CHEMISTRY; INTAKE POINTS; MULTICOMPONENTS; MULTIVARIATE STATISTICAL ANALYSIS; RIVER BASINS; WATER COMPOSITION;

DATA HANDLING; DRUG PRODUCTS; EFFLUENT TREATMENT; EFFLUENTS; PESTICIDES; POTABLE WATER; PRINCIPAL COMPONENT ANALYSIS; RIVERS; WATER QUALITY; WATER TREATMENT; WATERSHEDS;

RIVER POLLUTION;

ATENOLOL; BEZAFIBRATE; BISOPROLOL; CARBAMAZEPINE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DIAZEPAM; DRINKING WATER; HYDROCHLOROTHIAZIDE; IOPROMIDE; LIDOCAINE; LINCOMYCIN; LOSARTAN; METFORMIN; METOPROLOL; NAPROXEN; OXAZEPAM; PESTICIDE; PHENAZONE; PRIMIDONE; PROPRANOLOL; SOTALOL; SURFACE WATER; TEMAZEPAM; THEOPHYLLINE;

ANTHROPOGENIC SOURCE; DRINKING WATER; DRUG; PESTICIDE; PRINCIPAL COMPONENT ANALYSIS; RIVER BASIN; WASTE FACILITY; WATER POLLUTION; WATER QUALITY; WATER RESOURCE;

ANALYTIC METHOD; ARTICLE; CHEMICAL COMPOSITION; ELECTRIC CONDUCTIVITY; ELECTROSPRAY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; PH; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; RIVER BASIN; SEASONAL VARIATION; SOLID PHASE EXTRACTION; TURBIDITY; WASTE WATER MANAGEMENT; WASTE WATER TREATMENT PLANT; WATER ANALYSIS; WATER CONTAMINATION; WATER QUALITY; WATER SAMPLING;

DRINKING WATER; ENVIRONMENTAL CHEMISTRY; PHARMACEUTICAL; PRINCIPAL COMPONENT ANALYSIS; RIVER BASIN; WATER QUALITY;

BELGIUM; ENVIRONMENTAL MONITORING; FRANCE; NETHERLANDS; PESTICIDES; PHARMACEUTICAL PREPARATIONS; RIVERS; WATER POLLUTANTS, CHEMICAL;

MEUSE BASIN; NETHERLANDS;

EID: 84885844783     PISSN: 07307268     EISSN: 15528618     Source Type: Journal    
DOI: 10.1002/etc.2351     Document Type: Article

References (38)

1. Houtman CJ. 2010. Emerging contaminants in surface waters and their relevance for the production of drinking water in Europe. J Integr Environ Sci 7:271-295.
2. Bannink A. 2010. Jaarrapport 2010 Maas. Association of River Waterworks, RIWA, Maastricht, The Netherlands.
3. Van der Aa NGFM, Kommer GJ, Van Montfoort JE, Versteegh JFM. 2011. Demographic projections of future pharmaceutical consumption in The Netherlands. Water Sci Technol 63:825-831.
4. Loos R, Gawlik BM, Locoro G, Rimaviciute E, Contini S, Bidoglio G. 2009. EU-wide survey of polar organic persistent pollutants in European river waters. Environ Pollut 157:561-568.
5. Brooks BW, Huggett DB, Boxall AB. 2009. Pharmaceuticals and personal care products: Research needs for the next decade. Environ Toxicol Chem 28:2469-2472.
6. Kasprzyk-Hordern B, Dinsdale RM, Guwy AJ. 2008. The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK. Water Res 42:3498-3518.
7. Pal A, Gin KY-H, Lin AY-C, Reinhard M. 2010. Impacts of emerging organic contaminants on freshwater resources: Review of recent occurrences, sources, fate and effects. Sci Total Environ 408:6062-6069.
8. Ter Laak TL, van der Aa M, Houtman CJ, Stoks PG, van Wezel AP. 2010. Relating environmental concentrations of pharmaceuticals to consumption: A mass balance approach for the river Rhine. Environ Int 36:403-409.
9. Benotti MJ, Trenholm RA, Vanderford BJ, Holady JC, Stanford BD, Snyder SA. 2009. Pharmaceuticals and endocrine disrupting compounds in US drinking water. Environ Sci Technol 43:597-603.
10. Kuster M, de Alda MJ, Hernando MD, Petrovic M, Martin-Alonso J, Barcelo D. 2008. Analysis and occurrence of pharmaceuticals, estrogens, progestogens and polar pesticides in sewage treatment plant effluents, river water and drinking water in the Llobregat River basin (Barcelona, Spain). J Hydrol 358:112-123.
11. Versteegh JFM, Van der Aa NGFM, Dijkman E. 2007. Geneesmiddelen in drinkwater en drinkwaterbronnen. Resultaten van het meetprogramma 2005/2006. RIVM Report 703719016/2007. Dutch Ministry for Public Health and the Environment, Bilthoven, The Netherlands.
12. Benoist AP, Brinkman AG, Diepenbeek PMJA, Waals JMJ. 1998. Bekwaam, a model fit for reservoir design and management. Water Sci Technol 37:269-276.
13. Henning-de Jong I, Van Zelm R, Huijbregts MAJ, De Zwart D, Van der Linden TMA, Wintersen A, Posthuma L, De Meent DV. 2008. Ranking of agricultural pesticides in the Rhine-Meuse-Scheldt basin based on toxic pressure in marine ecosystems. Environ Toxicol Chem 27:737-745.
14. Ankley GT, Brooks BW, Huggett DB, Sumpter AJ. 2007. Repeating history: Pharmaceuticals in the environment. Environ Sci Technol 41:8211-8217.
15. Houtman CJ, Booij P, van der Valk KM, van Bodegom PM, van den Ende F, Gerritsen AA, Lamoree MH, Legler J, Brouwer A. 2007. Biomonitoring of estrogenic exposure and identification of responsible compounds in bream from Dutch surface waters. Environ Toxicol Chem 26:898-907.
16. Steen RJCA, van der Vaart J, Hiep M, Van Hattum B, Cofino WP, Brinkman UAT. 2001. Gross fluxes and estuarine behaviour of pesticides in the Scheldt estuary (1995-1997). Environ Pollut 115:65-79.
17. Nikolaou A, Meric S, Fatta D. 2007. Occurrence patterns of pharmaceuticals in water and wastewater environments. Anal Bioanal Chem 387:1225-1234.
18. Cahill JD, Furlong ET, Burkhardt MR, Kolpin D, Anderson LG. 2004. Determination of pharmaceutical compounds in surface- and ground-water samples by solid-phase extraction and high-performance liquid chromatography-electrospray ionization mass spectrometry. J Chromatogr A 1041:171-180.
19. Batt AL, Kostich MS, Lazorchak JM. 2008. Analysis of ecologically relevant pharmaceuticals in wastewater and surface water using selective solid-phase extraction and UHPLC-MS/MS. Anal Chem 80:5021-5030.
20. Scheurer M, Sacher F, Brauch HJ. 2009. Occurrence of the antidiabetic drug metformin in sewage and surface waters in Germany. J Environ Monit 11:1608-1613.
21. Pieters BJ, Vergouwen AA. ZORG: Zoeken naar oplossingen voor reductie van geneesmiddelen uit zorginstellingen. Deel B: metingen casestudie GGZ Instelling Waterschap De Dommel. 2011-W-01C. Grontmij Nederland, Houten, The Netherlands, 1-50.
22. Lekkerkerker-Teunissen K, Knol AH, van Altena LP, Houtman CJ, Verberk JQJC, Van Dijk JC. 2012. Serial ozone/peroxide/low pressure UV treatment for synergistic and effective organic micropollutant conversion. Sep Purif Technol 100:22-29.
23. Scheurer M, Michel A, Brauch HJ, Ruck W, Sacher F. 2012. Occurrence and fate of the antidiabetic drug metformin and its metabolite guanylurea in the environment and during drinking water treatment. Water Res 46:4790-4802.
24. Ottmar KJ, Colosi LM, Smith JA. 2012. Fate and transport of atorvastatin and simvastatin drugs during conventional wastewater treatment. Chemosphere 88:1184-1189.
25. Saari TI, Uusi-Oukari M, Ahonen J, Olkkola KT. 2011. Enhancement of GABAergic activity: Neuropharmacological effects of benzodiazepines and therapeutic use in anesthesiology. Pharmacol Rev 63:243-267.
26. Sacher F, Ehmann M, Gabriel S, Graf C, Brauch HJ. 2008. Pharmaceutical residues in the river Rhine-Results of a one-decade monitoring programme. J Environ Monit 10:664-670.
27. Hua WY, Bennett ER, Maio XS, Metcalfe CD, Letcher RJ. 2006. Seasonality effects on pharmaceuticals and s-triazine herbicides in wastewater effluent and surface water from the Canadian side of the upper Detroit River. Environ Toxicol Chem 25:2356-2365.
28. Volz J. Glyphosate and AMPA in the Meuse catchment: Results of the monitoring campaign 2008. Association of River Waterworks Meuse-RIWA, Werkendam, The Netherlands.
29. Moens M, Vroege M, Van Zanten O, Tamerus H, Renkens G. 2010. Uniek meetprogramma rondom de Dommel door Eindhoven. H2O 2010:16-18.
30. Ort C, Hollender J, Schaerer M, Siegrist H. 2009. Model-based evaluation of reduction strategies for micropollutants from wastewater treatment plants in complex river networks. Environ Sci Technol 43:3214-3220.
31. Dsikowitzky L, Schwarzbauer J, Kronimus A, Littke R. 2004. The anthropogenic contribution to the organic load of the Lippe River (Germany)-Part I: Qualitative characterisation of low-molecular weight organic compounds. Chemosphere 57:1275-1288.
32. Martinez Bueno MJ, Ucles S, Hernando MD, Davoli E, Fernandez-Alba AR. 2011. Evaluation of selected ubiquitous contaminants in the aquatic environment and their transformation products. A pilot study of their removal from a sewage treatment plant. Water Res 45:2331-2341.
33. De Wit M. 2008. From Rain to Meuse: Transboundary Water Management in Dry and Wet Periods. Veen Magazines, Diemen, The Netherlands.
34. Van der Aa NGFM, Kommer GJ, De Groot GM, Versteegh JFM. 2008. Geneesmiddelen in bronnen voor drinkwater. Monitoring, toekomstig gebruik en beleidsmaatregelen. RIVM Repotr 609715002. National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
35. Bruce GM, Pleus RC, Snyder SA. 2010. Toxicological relevance of pharmaceuticals in drinking water. Environ Sci Technol 44:5619-5626.
36. Johnson AC, Jürgens MD, Williams RJ, Kümmerer K, Kortenkamp A, Sumpter JP. 2008. Do cytotoxic chemotherapy drugs discharged into rivers pose a risk to the environment and human health? An overview and UK case study. J Hydrol 348:167-175.
37. Kumar A, Xagoraraki I. 2010. Pharmaceuticals, personal care products and endocrine-disrupting chemicals in U.S. surface and finished drinking waters: A proposed ranking system. Sci Total Environ 408:5972-5989.
38. Webb S, Ternes T, Gibert M, Olejniczak K. 2003. Indirect human exposure to pharmaceuticals via drinking water. Toxicol Lett 142:157-167.